IJGC’s Impact Factor Rises

We are delighted to share the 2019 impact factor for the International Journal of Gynecological Cancer of 2.095 (Journal Citation Reports, Clarivate Analytics), which ranked 41/82 in the Obstetrics and Gynecology category and 195/244 in the Oncology category.

IGCS congratulates IJGC Editor-in-Chief, Dr. Pedro Ramirez and the entire Editorial Team for the success of the journal. Their efforts are certainly evident in the transformation of the journal with new features and article types promoting research in the field of gynecologic cancer all over the world.

The quality and impact of journals are dependent on many different measures. IJGC has provided some of those metrics for International Journal of Gynecological Cancer, to reflect the latest 2019 data. Click here to view top most cited articles from each of the last two years, free to read.

Journal Metrics

Speed
Days to first decision: 16
Days from acceptance to publication: 29

Impact
2 year Impact Factor (JCR): 2.095
SciMago Journal Rank (SJR): 1.011
Eigenfactor: 0.01217
Citescore: 3.8

Reach
2019 total Content accesses: 310,000
Altmetric score: 2,688

2019 Readership Survey

The International Journal of Gynecological Cancer is conducting a readership survey to collect feedback from IGCS members and subscribers regarding journal content and educational offerings such as podcasts, video articles and different article types. Please complete the survey here. 

Patient Perspectives Roundtable

Virtual Patient Perspectives Roundtable
Patient Advocacy & Support in the Backdrop of COVID-19

Tuesday, June 30, 2020
View the recording of the session below.


Presenting Organizations:

[/su_row

This Virtual Roundtable—focused on gynecologic cancer patient advocacy and support—is an online version of the IGCS Patient Perspectives Roundtable Series. It is structured to adhere to the safety guidelines in place during the COVID-19 pandemic while addressing information gaps and needs and continuing the exchange of essential information in this constantly evolving environment.

Moderator

Maurício Magalhães Costa
Member, IGCS Council
Member, National Academy of Medicine
President, Senologic International Society
Coordinator, Breast Unit of Americas Center of Oncology
Brazil

Panelists

Endometrial Cancer Action Network for African-Americans (ECANA)

Kemi M. Doll
Project Lead, ECANA
Gynecologic Oncologist
University of Washington
USA

Margie Willis
Advocate, ECANA
Endometrial Cancer Survivor
USA

SHARE Cancer Support (Breast, Ovarian, and Uterine)

Kitty Silverman
Uterine Cancer Program Coordinator, SHARE
USA

Nefa-Tari Moore
Uterine Cancer Program Associate/Helpline Coordinator/Support Group Facilitator, SHARE
Ovarian & Uterine Cancer Survivor
USA

Women4Cancer Early Detection & Treatment

Benda Kithaka
Co-Founder/Chair, Women4Cancer Early Detection & Treatment
Kenya

 

 

About the IGCS Patient Perspectives Roundtable Series
During the COVID-19 pandemic and in its aftermath, IGCS will continue to be a global source of education and resources, training, public awareness, and advocacy. Virtual Roundtables will

  • facilitate first-hand assessment of patient community needs and concerns
  • provide vetted information, assessments, and guidance from key opinion leaders and seasoned survivors/advocates
  • address current patient and wider community concerns through live responses to question posted online during the session
  • promote strategic conversations with health care and research communities around specific issues
  • assist all in coming to workable solutions and strategies for moving forward during the COVID-19 pandemic and in its aftermath

Each 60- to 90-minute session will cover a specific topic important to the gynecologic cancer patient communities maneuvering through the health and cancer care system during and after COVID-19 and will include IGCS key opinion leaders, patients-caregivers, and other stakeholders appropriate to the topic.

Previous Virtual Roundtable
Patient Care & Clinical Trials in the Midst of COVID-19
May 23, 2020
This event was supported by a grant from the GOG Foundation, Inc.
Upcoming Virtual Roundtable
IGCS will host a Virtual Patient Perspectives Roundtable on September 10, 2020, during its xDigital Annual Global Meeting.

Welcome, SASGO!

We are so pleased to announce that the South African Society of Gynaecologic Oncology (SASGO) has joined the IGCS Strategic Alliance Partnership.

SASGO Members will now benefit from dual membership and gain access to IGCS Member benefits such as the Early Career Research & Publications Network,  the online member Education Portal (including the new Pathology Corner), AAGL’s SurgeryU video library, discounted registration for the IGCS Annual Global Meeting, and access to our online member community Social Link.

Greta Dreyer, who serves as SASGO President and as an IGCS Council Member, was instrumental in communicating with SASGO Council and Members and sharing feedback with IGCS leadership to discuss challenges and opportunities to collaborate and share resources to improve treatment of women affected by gynecologic cancers in South Africa.

SASGO was founded in 2006 to promote excellence in gynaecologic cancer care through training, research, and quality of care. They also advocate on behalf of women in South Africa by liaising with concerned governmental and non-governmental groupings, institutes for training and examination, authorities, and related advisory and research groups.

South Africa, with a population of 55 million, is a multiethnic society encompassing a wide variety of cultures and religions with 11 official languages. According to the International Agency for Research on Cancer, breast and cervical cancer are the most prevalent cancers affecting women in South Africa with cervical cancer being number one cause of cancer-related deaths. Vulvar, uterine, and ovarian cancer are also among the top eight most prevalent cancers in the country.

We look forward to our partnership with SASGO, to serve the gynecologic cancer professionals in the region, unite them with our global community, and to find ways to achieve our common goals to fight gynecologic cancers through training, education and public awareness.

IJGC Editorial Fellows

We are pleased to congratulate the five young gynecologic oncologists selected to serve as Editorial Fellows for the International Journal of Gynecological Cancer (IJGC). The fellows are IGCS Members and a part of the IGCS Early Career Research & Publications Network.

Geetu Bandoria
Indian Armed Forces
India
Arthur Hsu
National Taiwan University Hospital Hsin-Chu Branch
Taiwan
Sadie Jones
Cardiff University
Wales, UK
Navya Nair
Louisiana State University
USA
Florencia Noll
Hospital Italiano de Buenos Aires
Argentina

The IJGC Editorial Fellowship is a four-month appointment that matches the fellows with the Editor in Chief, Dr. Pedro Ramirez to gain experience in peer review processing, proposal/manuscript development, medical journal production, working with authors, editorial board management, and implementing a strategic vision plan.

Dr. Pedro Ramirez said, “We are very pleased to announce the selection of this outstanding group of gynecologic oncologists as the new Editorial Fellows of the International Journal of Gynecological Cancer. Looking forward to a very productive collaboration and to their innovative input in continuing to improve the quality of our journal. Congratulations!!”

The fellows will work on special projects based on personal areas of interest and the needs of the journal to further develop their skills to further their own research careers and effect change in the quality of medical research.

We are so pleased that IJGC has provided this fantastic opportunity for professional development to these members of the IGCS Early Career Research & Publications Network. The IGCS Early Career Network is open to all IGCS members within the first five years of completion of fellowship.

Sincerely,

Robert Coleman, MD
IGCS President Elect and Chair of the Early Career Research & Publications Network

Mary Eiken, MS
IGCS Chief Executive Officer

 

What the fellows have to say:

“Thrilled to be selected as IJGC Editorial fellow. Hoping to learn from the entire editorial team, and becoming a better authors & reviewer”
– Geetu Bhandoria

“It’s truly my honor to have such a great opportunity to serve as an editorial fellow for IJGC. I am thrilled about the activities in the fellowship and can’t wait to be connecting with doctors all around the globe. I am indebted to IGCS/IJGC as you provide exceptional learning programs for enthusiasts in the field. A shout out to the IGCS Early Career Research & Publications Network who are starting to fight gynecological cancer, together!”
– Arthur Hsu

“I am thrilled for this opportunity to gain an in depth understanding of the editorial process and be able to do so while collaborating with colleagues across the globe! Through this fellowship, I aspire to become a better scientific writer and more effectively mentor my trainees on the manuscript writing process. I look forward to using these new skills to help elevate the quality of gynecologic cancer research we publish and the oncologic care we provide here at Louisiana State University-New Orleans.”
-Navya Nair

“The possibility of participating in this program represents a wonderful challenge. This will be a great opportunity for me to get involved with the IGCS and learn about the development of protocols, manuscripts writing, reviewing processes, and also to encourage worldwide collaborative research projects. The IGCS Early Career Network allows me to continuously grow in my professional development and improve my patient’s care. I am grateful to have this unique opportunity!”
-Florencia Noll

IGCS 2020 xDigital Meeting

June 1, 2020

Dear Colleague,

Like many of you, the International Gynecologic Cancer Society (IGCS) leadership has been monitoring COVID-19 over the last several months. We are aware of the challenging times and our primary concern is for the health and safety of those of you in the global gynecologic oncology community who attend the IGCS Annual Global Meeting and of course the patients you serve.

The IGCS Council has decided that the best course of action is to postpone our previous plans to gather in Rome and to conduct the 2020 IGCS Annual Global Meeting as a fully digital meeting.

We are now re-launching the IGCS Annual Global Meeting, scheduled for September 10-13, 2020 utilizing innovative “xDigital” technology designed by our new service provider, iCrossing.

During this challenging time, we believe it is important now more than ever for health care professionals, survivors, and caregivers as well as our industry colleagues to come together on our new digital platform. We are committed to provide our members and delegates around the world with targeted educational programming, the latest scientific research in gynecologic cancers, and interactive networking opportunities. We have put a lot of thought and consideration into re-engineering IGCS 2020 with xDigital technology and are proud to bring you an enhanced experience that you can join from the comfort of your home or office.

Contributions of speakers, authors, and the work of the Scientific Program Committee will be realized in the xDigital environment, and abstracts will be published in the digital congress portal as well as the International Journal of Gynecological Cancer. We are committed to delivering industry symposia at our continued high level of engagement and to finding innovative and unique ways for participants to engage with industry and IGCS in our digital exhibition hall.

Please visit the meeting website to learn more about the IGCS xDigital Annual Global Meeting. Registration and abstract submission are now open! Abstracts will be accepted through July 15th.

www.igcsmeeting.com

It is important for the gynecologic oncology community to come together and continue to share research, experiences, and ideas and gather inspiration for the sake of caring for patients with gynecologic malignancies. IGCS has always served to unite the globe in the fight against gynecologic cancers and while we cannot be together face to face this year, we can still gather in this new way to present and hear the latest scientific research, discuss and share ideas, and connect with old friends while having the opportunity to meet new ones.

Prof. Roberto Angioli
IGCS President

Profs. Rainer Kimmig & Thomas Herzog
Co-Chairs, IGCS 2020 Scientific Program Committee

Learn more about the innovative xDigital platform by viewing this video demo.

Abstract Submission Deadline July 15

Abstract Submission Deadline: July 15, 2020

The 2020 IGCS Annual Global Meeting is being relaunched as a fully digital meeting. The meeting is scheduled for September 10-13, 2020 and will utilize innovative “xDigital” technology designed by our new service provider, iCrossing.

All abstracts must be original work, and not previously published or orally presented at other scientific meetings. Select posters will be chosen as oral presentations for featured poster sessions. The submission deadline has been extended to July 15, 2020.

Learn more about the meeting, register, and submit abstracts at igcsmeeting.com.

Abstract Topics:

Basic/Translational Science
Breast Cancer
Cervical Cancer
Clinical Trials in Progress
Diagnostics
Early Phase Clinical Trials
Endometrial Cancer
Fertility/Pregnancy
Genetics and Epidemiology
Global Health
Gynecologic Pathology/Cytology and Disease Pathogenesis

Imaging/Staging
Nursing and Health Care
Ovarian Cancer
Palliative Care
Patient Advocacy
Pre-Invasive Disease
Rare Tumors and Gestational Trophoblastic Neoplasia
Surgical Techniques and Perioperative Management
Symptom Management/Supportive Cancer Care
Trophoblastic Diseases
Uterine Cancer Including Sarcoma
Vulvar and Vaginal Cancer

If you have questions or need assistance, please email mandy.hansen@igcs.org

Learn more about the innovative xDigital platform by viewing this video demo.

IGCS-ISSTD Strategic Partnership

IGCS Members and Friends,

We are pleased to announce that IGCS has entered a strategic partnership with the International Society for the Study of Trophoblastic Diseases (ISSTD).

ISSTD aims to forge international collaborations between cooperative groups to improve the outcomes of women with trophoblastic diseases through education, research, and where possible clinical-trial development in a highly constructive and cost-effective manner.

Both IGCS and ISSTD consist of multidisciplinary professionals that include dedicated gynecologic oncologists, medical oncologists, clinical chemists, geneticists, pathologist, surgical oncologists, radiation oncologists and allied health professionals committed to the care of women with gynecological cancers. IGCS being a global organization can reach parts of the world where the disease is most prevalent and impacting lives.

We would like to share that IGCS and ISSTD leaderships who worked very closely in making the partnership goal oriented in achieving the following joint objectives of our organizations:

  • Early career research and professional development: to convene early career members for the purpose of developing and promoting research project ideas and to understand the importance of publishing and writing as critical components to their career development.
  • Provide mentorship and training opportunities to low resource settings through Project ECHO Virtual Tumor Board tele-mentoring (with ISSTD contributing GTD education)
  • Integrate educational programming exchanges between the IGCS Annual Global Meeting and the ISSTD Biennial World Congress on Gestational Trophoblastic Disease
  • Build a strong advocacy network among patient-survivors and caregivers to share experiences and promote public awareness and education regarding GTD
  • Strategize on data collection methods at sites with high prevalence of disease to learn more about ways of improving patient outcomes.

Together, we will certainly be stronger and reach higher levels of success in our common goals to serve the global community of gynecologic cancer professionals and the patients they care for.

Sincerely,

Roberto Angioli, MD
IGCS President

Ross Berkowitz, MD
ISSTD President

 

Surgical Film Festival

IGCS in partnership with AAGL is providing a free online surgical film festival narrated by expert surgeons in the field of gynecologic oncology. Attendees can participate in live discussion while viewing the surgical films and hear from the experts in the areas of ovarian and uterine cancers.

State-of-the-Art Surgical Film Festival: Ovarian & Uterine Cancers
Friday, May 8, 2020

8:00 a.m. CT/1:00 p.m. UTC (90 minutes)
REGISTER

Ovarian Cancer
50 minutes

In this session we will demonstrate many of the aspects of the surgical approach to patients with ovarian cancer. We will highlight both open and minimally invasive approaches.

Moderator Dr. Vance Broach
Memorial Sloan-Kettering Cancer Center
United States
Who do we take to the OR for Primary Debulking Surgery? Dr. Kara Long
Memorial Sloan-Kettering Cancer Center
United States
Modified Posterior Exenteration
(combined TAH BSO LAR)
Dr. Luis Chiva
Clínica Universidad de Navarra
Spain
Right Diaphragm Resection Dr. Reitan Ribeiro
Erasto Gaertner Hospital
Brazil
Left Upper Quadrant & Porta Hepatis Dissection Dr. Oliver Zivanovic
Memorial Sloan-Kettering Cancer Center
United States
MIS Interval Debulking Dr. Jose Alejandro Rauh-Hain
University of Texas, MD Anderson Cancer Center
United States

Uterine Cancer
40 minutes

This section will highlight specific surgical procedures for endometrial cancer and decision making for the surgical approach with the surgeons presenting their videos. We will also highlight the various surgical platforms available for endometrial cancer surgery.

Moderator Dr. Ane Gerda Zahl Eriksson
The Norwegian Radium Hospital, Oslo University Hospital
Norway
SLN Mapping in Uterine Cancer Dr. Rainer Kimmig
West German Cancer Center, University of Duisburg-Essen
Germany
Extraperitoneal Dissection Dr. Paulo Zanvettor
Aristides Maltez Hospital
Brazil
Para-aortic Lymph Node Dissection Dr. Eric LaBlanc
Centre Oscar Lambret
France

 

This film festival was organized by Vance Broach, Surgical Education Lead of the IGCS Education Committee.

Education Highlight: Pathology Corner

Education Highlight: New Pathology Corner

IGCS is excited to announce an all-new area of the education portal, the pathology corner.

Under the direction of Anna Plotkin, Pathology Work Group Lead, and with significant contributions from our Strategic Alliance Partner Members at the International Society of Gynecological Pathologists (ISGyP), the corner was created to streamline pathology related education curated specifically for gynecologic oncologists.

Key features in the Pathology Corner include:

  • Educational Paths: Recorded lectures and downloadable pathology resources categorized by disease site
  • Literature Highlights: Summaries of papers from ISGyP’s Endometrial Carcinoma Project published in the International Journal of Gynecological Pathology
  • Terms & Definitions: Commonly used IHC stains in gynecologic oncology
  • Ask a Pathologist: IGCS members may submit questions to the Pathology Work Group via email.

New features will be added in the coming months, including interesting cases and additional educational paths. Feedback and suggestions are welcomed at pathology@igcs.org.

Anna Plotkin, MD IGCS Pathology Work Group Lead

We would like to acknowledge and express gratitude to our work group members for their efforts: Anna Plotkin, Work Group Lead (Canada), Blake Gilks (Canada), Siobhan O’Connor (USA), Joseph Rabban (USA), Adrian Suarez (USA), Gulisa Turashvili (Canada), and Rachael van der Griend (New Zealand) and all the contributors who have agreed to share content.

We hope you enjoy the new educational content in the Pathology Corner of the IGCS Member Education Portal!